Clinical Trials Logo

Chronic Widespread Pain clinical trials

View clinical trials related to Chronic Widespread Pain.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT05811663 Completed - Fibromyalgia Clinical Trials

Health Care Use and Costs of Functional Somatic Disorders

Start date: November 10, 2011
Phase:
Study type: Observational

The goal of this observational case-control study is to learn about direct healthcare use and costs of functional somatic disorders. The aim of the proposed study is to investigate the use and costs of direct healthcare for individuals with functional somatic disorders. Researchers will compare direct healthcare use and costs of individuals with functional somatic disorders and compare them with that of healthy controls and individuals with other severe physical disease, respectively.

NCT ID: NCT03434899 Completed - Clinical trials for Chronic Widespread Pain

Effects of Physical Activity With Online Support for Individuals With Chronic Widespread Pain (CWP)

GAU-E
Start date: February 15, 2018
Phase: N/A
Study type: Interventional

The aim is to evaluate a novel treatment routine where contact through a smart phone/computer is used for online support for patients suffering from chronic widespread pain (CWP). The outline is that patients are encouraged to perform physical activity during a period of 12 months with online support from a physical therapist.

NCT ID: NCT03180554 Completed - Fibromyalgia Clinical Trials

Body Versus Machine: Deep Breathing Versus Vagus Stimulation for the Treatment of Fibromyalgia

Start date: March 15, 2019
Phase: N/A
Study type: Interventional

This randomized controlled trial aims to compare the efficacy of two vagal nerve innervation treatments, motivational nondirective resonance breathing and transcutaneous vagus nerve stimulation, on heart rate variability and pain intensity in patients suffering from CWP. This project tests new and potentially effective means of treating a major global and public health concern where prevalence is high, disability is severe, and treatment options are limited.

NCT ID: NCT03058224 Completed - Fibromyalgia Clinical Trials

Efficacy and Safety of IGN-ES001 in Chronic Widespread Pain With or Without Fibromyalgia

Start date: February 16, 2017
Phase: N/A
Study type: Interventional

This is a randomized, double-blind, placebo-controlled exploratory trial to investigate efficacy and safety of food supplement IGN-ES001 in patients with chronic widespread pain (CWP) with or without fibromyalgia (FM).

NCT ID: NCT02872129 Completed - Fibromyalgia Clinical Trials

12-years Follow-up on 166 Female Patients With Fibromyalgia or Chronic Widespread Pain

Start date: May 2016
Phase:
Study type: Observational

A 12-year follow-up of 166 women with fibromyalgia (FM) or chronic widespread pain (CWP) in western Sweden. The 166 women participated in a Randomised Controlled Trial called GAU in 2004-2005, aiming to investigate the effect of pool exercise and patient education. The primary aim of the present study is to examine the change of symptoms after 11-12 years in 166 women with FM or CWP and also investigate predictors of change of symptoms and work ability. The 166 women will be asked to participate in the present follow-up study. The follow-up examination comprises a standardised interview of symptoms and demographic variables, a battery of self-administered questionnaires and tests of physical function.

NCT ID: NCT02688569 Completed - Chronic Insomnia Clinical Trials

Sleep and Pain Intervention for Chronic Widespread Pain Pilot Study

SPIN-CWP
Start date: October 2016
Phase: N/A
Study type: Interventional

This randomized controlled clinical trial will examine the effects of Cognitive Behavioral Therapy (CBT-) in patients with comorbid chronic widespread pain (CWP) and insomnia. Specific Aims: 1. To examine the clinical and health characteristics, including sleep, pain, fatigue, cognitive abilities, and cardiovascular health in patients with comorbid CWP and insomnia. 2. To examine changes in the primary clinical outcomes, including chronic pain, complaints of poor sleep, and fatigue compared to the waitlist control (WLC). 3. To examine changes in the secondary clinical outcomes, including mood, daytime functioning, cognitive functioning, and cardiovascular health compared WLC. 4. To examine the mechanistic variables, including arousal (heart rate variability, HRV), CS (thermal response) and neural plasticity (brain function and structure) - compared to WLC.

NCT ID: NCT02190474 Completed - Fibromyalgia Clinical Trials

Mindfulness Interventions and Chronic Widespread Pain in Adolescents

Start date: July 2014
Phase: N/A
Study type: Interventional

The primary objective of this study to determine the feasibility and acceptability of a mindfulness intervention for adolescents with juvenile fibromyalgia/ chronic widespread pain and other similar chronic symptoms.

NCT ID: NCT01352052 Completed - Fibromyalgia Clinical Trials

Interdisciplinary Rehabilitation of Patients With Chronic Widespread Pain

IMPROvE
Start date: May 2011
Phase: N/A
Study type: Interventional

The primary objective of the current study is to evaluate the outcome of an interdisciplinary multi-component rehabilitation programme customized to patients with chronic widespread pain (CWP) based on multidimensional diagnostic assessment including sub-grouping, and aiming to improve functional ability in everyday life. The hypothesis is that a patient-focused multi-disciplinary rehabilitation approach will improve both functional ability and quality of life for patients with CWP.

NCT ID: NCT00521807 Completed - Clinical trials for Chronic Widespread Pain

Hypnosis as a Treatment of Chronic Widespread Pain in General Practice. A Pilot Study.

Start date: March 2001
Phase: N/A
Study type: Interventional

Objective: The study was performed to evaluate the effect of a standardized hypnosis treatment used in general practice for patients with chronic widespread pain (CWP). Design: A randomized control group-controlled study. Setting and subjects: 16 patients were randomized into a treatment group or a control group, each constituting eight patients. Seven patients in the treatment group completed the schedule. After the control period, five of the patients in the control group also received treatment, making a total of 12 patients having completed the treatment sessions. Intervention: The intervention group went through a standardized hypnosis treatment with ten consecutive therapeutic sessions once a week, each lasting for about 30 minutes, focusing on ego-strengthening, relaxation, releasing muscular tension and increasing self-efficacy. Main outcome measures: A questionnaire was developed in order to calibrate the symptoms before and after the 10 weeks period, and the results were interpolated into a scale from 0 to 100, increasing numbers representing increasing suffering.